NOACs vs. Warfarin for Stroke Prevention in Nonvalvular Atrial Fibrillation.

Cureus · 2017 · PMC5572042 · PMID 28845374

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

borderline significantno p-value reported

Death from any cause was borderline significant at 3.52% with apixaban and 3.94% with warfarin (HR 0.89, 95% CI, 0.80 to 0.99).

also in 11,409 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.